Gilbert Technologies is a Dutch company that specializes in designing and developing unique and innovative medical devices. Their aim is to improve healthcare and patient care while offering a better quality of life through sustainable health technologies. Their flagship product is a novel medical inhalation device that boasts market-leading lung deposition characteristics for various pulmonary medicine administration, including Cystic Fibrosis (CF), Asthma, Oncology (Lung cancer), Pulmonary Arterial Hypertension, and other respiratory conditions.

Beyond their inhaler device, Gilbert Technologies also focuses on therapeutic applications such as pain management, vaccination, and transplantation. They believe in turning complexity into simplicity, expanding access to healthcare, and enhancing patient adherence. The company's strategy is rooted in science-based innovation, aiming to deliver better patient outcomes and leading in certain growing areas of healthcare.

Notably, their EHDA technology has garnered attention from experts in the field for its potential to offer unique benefits in aerosolization and medication targeting for respiratory diseases. Gilbert Technologies collaborates with renowned institutions like TU Delft, NHL University of Applied Sciences, and University Medical Center Utrecht. For more information and updates, please visit their website or follow Gilbert Technologies on social media